Literature DB >> 2166296

[Microencapsulization of cholecalciferol by coacervation].

J Sawicka1.   

Abstract

Microcapsules with crystalline cholecalciferol were obtained by the use of gelatin (type A and B) as a main covering component by both simple and complex coacervation methods. The properties of the obtained microcapsules were determined by their size, release in gastric and intestinal juices, coat/core ratio, the content of cholecalciferol and its liberation. It was observed that both in the simple and complex coacervation, regardless of the type of gelatin used in the procedure, the effectiveness of the process and the properties of the microcapsules depend on coat/core ratio. In simple coacervation method optimal results were achieved when coat/core ratio was 0.25:1. In complex coacervation method optimal ratio was 0.5:1.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2166296

Source DB:  PubMed          Journal:  Pharmazie        ISSN: 0031-7144            Impact factor:   1.267


  4 in total

1.  Evaluation of anticancer effects of carboplatin-gelatin nanoparticles in different sizes synthesized with newly self-assembly method by exposure to IR light.

Authors:  Ferdane Danışman-Kalındemirtaş; İshak Afşin Kariper; Gökçe Erdemir; Esra Sert; Serap Erdem-Kuruca
Journal:  Sci Rep       Date:  2022-06-23       Impact factor: 4.996

Review 2.  Nanomaterials for Protein Delivery in Anticancer Applications.

Authors:  Anne Yau; Jinhyung Lee; Yupeng Chen
Journal:  Pharmaceutics       Date:  2021-01-25       Impact factor: 6.321

Review 3.  Protein nanoparticles as drug delivery carriers for cancer therapy.

Authors:  Warangkana Lohcharoenkal; Liying Wang; Yi Charlie Chen; Yon Rojanasakul
Journal:  Biomed Res Int       Date:  2014-03-20       Impact factor: 3.411

Review 4.  Protein Based Nanostructures for Drug Delivery.

Authors:  Deepali Verma; Neha Gulati; Shreya Kaul; Siddhartha Mukherjee; Upendra Nagaich
Journal:  J Pharm (Cairo)       Date:  2018-05-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.